欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号
CZ/H/0142/002
药品名称
Sibutramine Teva 15 mg tobolky
活性成分
Sibutramine hydrochloride 15.0 mg
剂型
Capsule, hard
上市许可持有人
TEVA PHARMACEUTICALS CR s.r.o. Brno Czech Republic
参考成员国 - 产品名称
Czech Republic (CZ)
互认成员国 - 产品名称
Portugal (PT)
Spain (ES)
Ireland (IE)
Denmark (DK)
Sibutramin "Teva"
Romania (RO)
Sibutramină Teva 15 mg capsule
Bulgaria (BG)
Meissa
Estonia (EE)
Lithuania (LT)
Sibutramine Teva 15 mg kietos kapsulės
Latvia (LV)
Sibutramine Teva 15 mg cietās kapsulas
Italy (IT)
France (FR)
United Kingdom (Northern Ireland) (XI)
Luxembourg (LU)
Belgium (BE)
Germany (DE)
Sibutramin Teva 15 mg Hartkapseln
Sweden (SE)
Sibutramine Teva
Greece (EL)
许可日期
2008/02/06
最近更新日期
2024/08/19
药物ATC编码
A08AA10 sibutramine
申请类型
TypeLevel1：
Abridged
TypeLevel2：
Additional Strength/Form
TypeLevel3：
Generic
TypeLevel4：
Chemical Substance
TypeLevel5：
Prescription Only
附件文件下载
Final PL
|
CZ_H_142_01_2_DC_SibutramineTeva10mg_15mg_PIL_Day210 _ corr _ final
Date of last change:2024/09/06
Final SPC
|
CZ_H_142_01_2_DC_SibutramineTeva15 mg_SPC_Day210 _ corr _ final
Date of last change:2024/09/06
Final Labelling
|
CZ_H_142_01_2_DC_SibutramineTeva15mg_Labelling_Day210 _ corr _ final
Date of last change:2024/09/06
市场状态
Positive
©2006-2026
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase